| Eye Max Pllc | |
|
4051 Nicholasville Rd, Lexington, KY 40503 | |
| (859) 272-1422 | |
| (859) 273-4582 |
| Full Name | Eye Max Pllc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 4051 Nicholasville Rd, Lexington, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144362559 | NPI | - | NPPES |
| 000000360202 | Other | KY | BLUE CROSS BLUE SHIELD |
| 77903912 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1455DT (Kentucky) | Primary |
| Provider Name | Kari Carpenter Mattson |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1306891361 PECOS PAC ID: 1355398173 Enrollment ID: I20050405000123 |
News Archive
Doctors who have completed training in internal medicine are in general poorly prepared for jobs as primary care physicians, most notably lacking the knowledge to best care for patients with chronic conditions such as diabetes, hypertension and high cholesterol, new Johns Hopkins research suggests.
As the importance of steroids in the regulation of bioprocesses has increased so has the demand for fast screening methods for their detection. HPLC is a highly regarded analytical technique for pharmaceutical applications due to its unrivalled analytical validation characteristics; including accuracy, precision, limit of detection, specificity, linearity and range, and ruggedness.
Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that it has filed an Investigational New Drug application with the U.S. Food and Drug Administration to initiate a Phase IIb multi-center, 100-patient clinical trial.
UNAIDS Executive Director Michel Sidibe in New York on Monday signed a partnership agreement with several non-governmental organizations (NGOs) pledging to work towards eliminating mother-to-child transmission of HIV in Africa, Agence France-Presse reports. Presidents Abdoulaye Wade of Senegal and Yoweri Museveni of Uganda attended the signing ceremony.
StemCells, Inc. announced today that is has filed an application with Swissmedic, the Swiss regulatory agency for therapeutic products, to conduct a clinical trial in Switzerland of the Company's HuCNS-SC® purified human neural stem cells in chronic spinal cord injury patients. If authorized, the study would enroll patients who are three to 12 months post-injury.
› Verified 7 days ago
| Provider Name | Suzannah Rowland Rich |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1518993583 PECOS PAC ID: 1153378989 Enrollment ID: I20050405000140 |
News Archive
Doctors who have completed training in internal medicine are in general poorly prepared for jobs as primary care physicians, most notably lacking the knowledge to best care for patients with chronic conditions such as diabetes, hypertension and high cholesterol, new Johns Hopkins research suggests.
As the importance of steroids in the regulation of bioprocesses has increased so has the demand for fast screening methods for their detection. HPLC is a highly regarded analytical technique for pharmaceutical applications due to its unrivalled analytical validation characteristics; including accuracy, precision, limit of detection, specificity, linearity and range, and ruggedness.
Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that it has filed an Investigational New Drug application with the U.S. Food and Drug Administration to initiate a Phase IIb multi-center, 100-patient clinical trial.
UNAIDS Executive Director Michel Sidibe in New York on Monday signed a partnership agreement with several non-governmental organizations (NGOs) pledging to work towards eliminating mother-to-child transmission of HIV in Africa, Agence France-Presse reports. Presidents Abdoulaye Wade of Senegal and Yoweri Museveni of Uganda attended the signing ceremony.
StemCells, Inc. announced today that is has filed an application with Swissmedic, the Swiss regulatory agency for therapeutic products, to conduct a clinical trial in Switzerland of the Company's HuCNS-SC® purified human neural stem cells in chronic spinal cord injury patients. If authorized, the study would enroll patients who are three to 12 months post-injury.
› Verified 7 days ago
| Provider Name | Harold C Gregory |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1912010182 PECOS PAC ID: 6305888504 Enrollment ID: I20050609000009 |
News Archive
Doctors who have completed training in internal medicine are in general poorly prepared for jobs as primary care physicians, most notably lacking the knowledge to best care for patients with chronic conditions such as diabetes, hypertension and high cholesterol, new Johns Hopkins research suggests.
As the importance of steroids in the regulation of bioprocesses has increased so has the demand for fast screening methods for their detection. HPLC is a highly regarded analytical technique for pharmaceutical applications due to its unrivalled analytical validation characteristics; including accuracy, precision, limit of detection, specificity, linearity and range, and ruggedness.
Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that it has filed an Investigational New Drug application with the U.S. Food and Drug Administration to initiate a Phase IIb multi-center, 100-patient clinical trial.
UNAIDS Executive Director Michel Sidibe in New York on Monday signed a partnership agreement with several non-governmental organizations (NGOs) pledging to work towards eliminating mother-to-child transmission of HIV in Africa, Agence France-Presse reports. Presidents Abdoulaye Wade of Senegal and Yoweri Museveni of Uganda attended the signing ceremony.
StemCells, Inc. announced today that is has filed an application with Swissmedic, the Swiss regulatory agency for therapeutic products, to conduct a clinical trial in Switzerland of the Company's HuCNS-SC® purified human neural stem cells in chronic spinal cord injury patients. If authorized, the study would enroll patients who are three to 12 months post-injury.
› Verified 7 days ago
| Provider Name | Clay Sterling Mattson |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1134132517 PECOS PAC ID: 9830110808 Enrollment ID: I20051219000305 |
News Archive
Doctors who have completed training in internal medicine are in general poorly prepared for jobs as primary care physicians, most notably lacking the knowledge to best care for patients with chronic conditions such as diabetes, hypertension and high cholesterol, new Johns Hopkins research suggests.
As the importance of steroids in the regulation of bioprocesses has increased so has the demand for fast screening methods for their detection. HPLC is a highly regarded analytical technique for pharmaceutical applications due to its unrivalled analytical validation characteristics; including accuracy, precision, limit of detection, specificity, linearity and range, and ruggedness.
Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that it has filed an Investigational New Drug application with the U.S. Food and Drug Administration to initiate a Phase IIb multi-center, 100-patient clinical trial.
UNAIDS Executive Director Michel Sidibe in New York on Monday signed a partnership agreement with several non-governmental organizations (NGOs) pledging to work towards eliminating mother-to-child transmission of HIV in Africa, Agence France-Presse reports. Presidents Abdoulaye Wade of Senegal and Yoweri Museveni of Uganda attended the signing ceremony.
StemCells, Inc. announced today that is has filed an application with Swissmedic, the Swiss regulatory agency for therapeutic products, to conduct a clinical trial in Switzerland of the Company's HuCNS-SC® purified human neural stem cells in chronic spinal cord injury patients. If authorized, the study would enroll patients who are three to 12 months post-injury.
› Verified 7 days ago
| Provider Name | Allyson N Lane |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1982854717 PECOS PAC ID: 5092842849 Enrollment ID: I20100427000467 |
News Archive
Doctors who have completed training in internal medicine are in general poorly prepared for jobs as primary care physicians, most notably lacking the knowledge to best care for patients with chronic conditions such as diabetes, hypertension and high cholesterol, new Johns Hopkins research suggests.
As the importance of steroids in the regulation of bioprocesses has increased so has the demand for fast screening methods for their detection. HPLC is a highly regarded analytical technique for pharmaceutical applications due to its unrivalled analytical validation characteristics; including accuracy, precision, limit of detection, specificity, linearity and range, and ruggedness.
Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that it has filed an Investigational New Drug application with the U.S. Food and Drug Administration to initiate a Phase IIb multi-center, 100-patient clinical trial.
UNAIDS Executive Director Michel Sidibe in New York on Monday signed a partnership agreement with several non-governmental organizations (NGOs) pledging to work towards eliminating mother-to-child transmission of HIV in Africa, Agence France-Presse reports. Presidents Abdoulaye Wade of Senegal and Yoweri Museveni of Uganda attended the signing ceremony.
StemCells, Inc. announced today that is has filed an application with Swissmedic, the Swiss regulatory agency for therapeutic products, to conduct a clinical trial in Switzerland of the Company's HuCNS-SC® purified human neural stem cells in chronic spinal cord injury patients. If authorized, the study would enroll patients who are three to 12 months post-injury.
› Verified 7 days ago
| Provider Name | Shelby Henderson |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1861019283 PECOS PAC ID: 1658794268 Enrollment ID: I20200714003277 |
News Archive
Doctors who have completed training in internal medicine are in general poorly prepared for jobs as primary care physicians, most notably lacking the knowledge to best care for patients with chronic conditions such as diabetes, hypertension and high cholesterol, new Johns Hopkins research suggests.
As the importance of steroids in the regulation of bioprocesses has increased so has the demand for fast screening methods for their detection. HPLC is a highly regarded analytical technique for pharmaceutical applications due to its unrivalled analytical validation characteristics; including accuracy, precision, limit of detection, specificity, linearity and range, and ruggedness.
Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that it has filed an Investigational New Drug application with the U.S. Food and Drug Administration to initiate a Phase IIb multi-center, 100-patient clinical trial.
UNAIDS Executive Director Michel Sidibe in New York on Monday signed a partnership agreement with several non-governmental organizations (NGOs) pledging to work towards eliminating mother-to-child transmission of HIV in Africa, Agence France-Presse reports. Presidents Abdoulaye Wade of Senegal and Yoweri Museveni of Uganda attended the signing ceremony.
StemCells, Inc. announced today that is has filed an application with Swissmedic, the Swiss regulatory agency for therapeutic products, to conduct a clinical trial in Switzerland of the Company's HuCNS-SC® purified human neural stem cells in chronic spinal cord injury patients. If authorized, the study would enroll patients who are three to 12 months post-injury.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eye Max Pllc 4051 Nicholasville Rd, Lexington, KY 40503 Ph: (859) 272-1422 | Eye Max Pllc 4051 Nicholasville Rd, Lexington, KY 40503 Ph: (859) 272-1422 |
News Archive
Doctors who have completed training in internal medicine are in general poorly prepared for jobs as primary care physicians, most notably lacking the knowledge to best care for patients with chronic conditions such as diabetes, hypertension and high cholesterol, new Johns Hopkins research suggests.
As the importance of steroids in the regulation of bioprocesses has increased so has the demand for fast screening methods for their detection. HPLC is a highly regarded analytical technique for pharmaceutical applications due to its unrivalled analytical validation characteristics; including accuracy, precision, limit of detection, specificity, linearity and range, and ruggedness.
Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that it has filed an Investigational New Drug application with the U.S. Food and Drug Administration to initiate a Phase IIb multi-center, 100-patient clinical trial.
UNAIDS Executive Director Michel Sidibe in New York on Monday signed a partnership agreement with several non-governmental organizations (NGOs) pledging to work towards eliminating mother-to-child transmission of HIV in Africa, Agence France-Presse reports. Presidents Abdoulaye Wade of Senegal and Yoweri Museveni of Uganda attended the signing ceremony.
StemCells, Inc. announced today that is has filed an application with Swissmedic, the Swiss regulatory agency for therapeutic products, to conduct a clinical trial in Switzerland of the Company's HuCNS-SC® purified human neural stem cells in chronic spinal cord injury patients. If authorized, the study would enroll patients who are three to 12 months post-injury.
› Verified 7 days ago
Dr. John D Mackey, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 1240 Belmar Ln, Lexington, KY 40515 Phone: 859-272-8181 | |
Breyne Louise Middleton, OD Optometrist Medicare: Medicare Enrolled Practice Location: 2250 Leestown Rd, Lexington, KY 40511 Phone: 859-233-4511 Fax: 859-281-3934 | |
Dr. Matthew Christopher Simpson, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: Va Medical Center, 1101 Veteran's Dr, Lexington, KY 40502 Phone: 317-902-0423 | |
Bilal Ahmad, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4140 Briar Hill Rd, Lexington, KY 40516 Phone: 859-433-1964 | |
Dr. Rebecca Hope Lanham, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 340 Meijer Way, Lexington, KY 40503 Phone: 859-278-0055 Fax: 859-277-4490 | |
Mao Yang, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2250 Leestown Rd, Lexington, KY 40511 Phone: 828-514-2750 | |
Dr. John Webster Zent, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 340 Meijer Way, Lexington, KY 40503 Phone: 859-278-2020 |